Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways
- 6 February 2013
- journal article
- research article
- Published by Springer Nature in Basic Research in Cardiology
- Vol. 108 (2) , 333
Abstract
The poor viability of transplanted stem cells hampers their therapeutic efficacy for treatment of myocardial infarction. The aim of this study was to investigate whether rosuvastatin improved survival of adipose-derived mesenchymal stem cells (AD-MSCs) after transplantation into infarcted hearts. AD-MSCs isolated from Tg(Fluc-egfp) mice which constitutively express both firefly luciferase (Fluc) and enhanced green fluorescent protein were transplanted into infarcted hearts with or without rosuvastatin administration. Longitudinal in vivo bioluminescence imaging and histological staining revealed that rosuvastatin enhanced the survival of engrafted AD-MSCs. Furthermore, combined therapy of AD-MSC and rosuvastatin reduced fibrosis, decreased cardiomyocyte apoptosis, and preserved heart function. AD-MSCs were then subjected to hypoxia and serum deprivation injury in vitro to mimic the ischemic environment. Rosuvastatin (10−6 mmol/L) enhanced the viability and paracrine effect of AD-MSCs, and decreased their apoptotic rate. Western blotting revealed that rosuvastatin supplementation increased Akt and ERK phosphorylation, which resulted in FoxO3a phosphorylation and nuclear export. In addition, rosuvastatin administration decreased the pro-apoptotic proteins Bim and Bax, and increased the anti-apoptotic proteins Bcl-xL and Bcl-2. Furthermore, these effects were abolished by PI3K inhibitor LY294002 and MEK1/2 inhibitor U0126. This study demonstrates that rosuvastatin may improve the survival of engrafted AD-MSCs at least in part through the PI3K/Akt and MEK/ERK1/2 signaling pathways. Combination therapy with rosuvastatin and AD-MSCs has a synergetic effect on improving myocardial function after infarction.Keywords
This publication has 48 references indexed in Scilit:
- Cardiac progenitors derived from reprogrammed mesenchymal stem cells contribute to angiomyogenic repair of the infarcted heartBasic Research in Cardiology, 2012
- The landscape of somatic copy-number alteration across human cancersNature, 2010
- IFATS Collection: Human Adipose Tissue-Derived Stem Cells Induce Angiogenesis and Nerve Sprouting Following Myocardial Infarction, in Conjunction with Potent Preservation of Cardiac FunctionStem Cells, 2009
- Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxiaNature, 2008
- In vivo imaging and evaluation of different biomatrices for improvement of stem cell survivalJournal of Tissue Engineering and Regenerative Medicine, 2007
- FoxOs in Tumor Suppression and Stem Cell MaintenanceCell, 2007
- Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's Lymphoma Ascites tumor in miceClinica Chimica Acta, 2006
- In Vivo Visualization of Embryonic Stem Cell Survival, Proliferation, and Migration After Cardiac DeliveryCirculation, 2006
- FoxOs at the Crossroads of Cellular Metabolism, Differentiation, and TransformationCell, 2004
- BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytesNature, 2002